전체 프로그램

ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved257 programs
AntibodyCurated CorestaleNovartisPhase 3

Ofatumumab (Ofatumumab)

Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma · Leukemia

#Leukemia#Antibody#Phase3#BioJungboMoa-pick#Popular+5
Trials 85Status Recruiting
AntibodyLimited DatastaleRochePreclinical

MPDL3280A (Atezolizumab, Atezolizumab (MPDL3280A))

Non-Small Cell Lung Cancer · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#Antibody#Preclinical#Popular#monoclonal-antibody+1
Trials 60Status Active
AntibodyLimited DatastaleBristol Myers SquibbPhase 2

nivolumab (Opdivo, ipilimumab + nivolumab)

Solid Tumor; Non Small Cell Lung Cancer · Solid Tumor

#SolidTumor#Antibody#Phase2#Popular#monoclonal-antibody+2
Trials 60Status Recruiting
AntibodyLimited DatastaleRegeneronPhase 2

Cemiplimab + Fianlimab [Fixed Dose Combination (FDC, Cemiplimab + Fianlimab [Fixed Dose Combination, Cemiplimab + Fianlimab [Fixed Dose Combination (FDC)])

Ovarian Cancer; Fallopian Tube Cancer · Ovarian Cancer

#OvarianCancer#Antibody#Phase2#Popular#monoclonal-antibody+3
Trials 59Status Recruiting
ADCStandard DatabasestaleRocheDM1 via butelase-1 with ABD…Phase 3

T-DM1 (Trastuzumab emtansine, Trastuzumab emtansine (T-DM1))

Unrespectable Locally Advanced and or Metastatic HER2 Positive Breast Cancer Participants · HER2

#HER2#ADC#Phase3#Popular#antibody-drug-conjugate+4
Trials 59Status Recruiting
CGTStandard DatabasestaleSMT bio Co., Ltd.Phase 2

allogeneic Natural Killer cell ('SMT-NK' Inj, 'SMT-NK' Inj (allogeneic Natural Killer cell))

Biliary Tract Cancer · Biliary Tract Cancer

#BiliaryTractCancer#CGT#Phase2#Popular#cell-gene-therapy+4
Trials 58Status Active
CGTLimited DatastaleCoronado Biosciences, Inc.Phase 2

Allogeneic natural killer cells (Allogeneic natural killer cells)

Leukemia; Lymphoma · Fallopian Tube Cancer

#FallopianTubeCancer#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 58Status Discontinued
AntibodyLimited DatastaleWei-Che KoPhase 3

Canakinumab (Canakinumab)

Skin Inflammation; Allergic Contact Dermatitis · Skin Inflammation

#SkinInflammation#Antibody#Phase3#Popular#monoclonal-antibody+3
Trials 57Status Recruiting
ADCLimited DatastaleMerck Sharp & Dohme LLCGovitecan in gynecologic ma…Phase 3

sacituzumab govitecan (Trodelvy, Sacituzumab tirumotecan)

Non-small Cell Lung Cancer; Solid Tumors · Endometrial Cancer

#EndometrialCancer#ADC#Phase3#Popular#antibody-drug-conjugate+5
Trials 57Status Recruiting
CGTLimited DatastaleAllife Medical Science and Tech…Phase 2

Cytokine-induced killer cells (Cytokine-induced killer cells)

Ovarian Carcinoma · Cholangiocarcinoma

#Cholangiocarcinoma#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 56Status Recruiting
AntibodyLimited DatastaleAstraZenecaPhase 3

durvalumab (Imfinzi, MEDI4736, MEDI4736 (Durvalumab) + Tremelimumab)

Non-Small-Cell Lung Carcinoma NSCLC · Advanced Solid Malignancies

#AdvancedSolidMalignancies#Antibody#Phase3#Popular#monoclonal-antibody+2
Trials 56Status Recruiting
CGTLimited DatastaleShenzhen Hornetcorn Bio-technol…Preclinical

CIK cell therapy (CIK cell therapy)

Non Small Cell Lung Cancer · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#CGT#Preclinical#Popular#cell-gene-therapy+4
Trials 54Status Active
AntibodyLimited DatastaleJiangsu Hansoh Pharmaceutical C…Phase 2

adebrelimab and chemotherapy (adebrelimab and chemotherapy)

Efficacy and Safety of Neoadjuvant Immunotherapy for Small Cell Lung Cancer · Efficacy and Safety of Neoadjuvant Immun

#EfficacyandSafetyofNeoadjuvantIm#Antibody#Phase2#Popular#monoclonal-antibody+1
Trials 54Status Recruiting
CGTLimited DatastaleThe Leukemia and Lymphoma Socie…Phase 1

CD22 CAR (CD22 CAR)

B-ALL; B-cell Non Hodgkin Lymphoma · CD22

#CD22#CGT#Phase1#Popular#cell-gene-therapy+5
Trials 53Status Active
AntibodyCurated CorestaleJanssenPhase 3

Amivantamab (Amivantamab)

Carcinoma, Non-Small-Cell Lung · Colorectal Cancer

#ColorectalCancer#Antibody#Phase3#BioJungboMoa-pick#Popular+5
Trials 51Status Recruiting
CGTLimited DatastaleAllife Medical Science and Tech…Phase 1

CRISPR/Cas9 (CRISPR/Cas9)

Human Papillomavirus-Related Malignant Neoplasm · Human Papillomavirus-Related Malignant N

#HumanPapillomavirus-RelatedMalig#CGT#Phase1#Popular#cell-gene-therapy+4
Trials 50Status Active
AntibodyLimited DatastaleWei-Che KoPhase 3

Sarilumab (Sarilumab)

Skin Inflammation; Allergic Contact Dermatitis · Melanoma

#Melanoma#Antibody#Phase3#Popular#monoclonal-antibody+4
Trials 50Status Recruiting
AntibodyLimited DatastaleXuekui LiuPhase 2

Zimberelimab (Zimberelimab)

Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable · Prostatic Neoplasms, Castration-Resistan

#ProstaticNeoplasmsCastration-Res#Antibody#Phase2#Popular#monoclonal-antibody+2
Trials 50Status Recruiting
AntibodyLimited DatastaleMridula George, MDPhase 2

Retifanlimab (Retifanlimab)

Anatomic Stage IV Breast Cancer AJCC v8; Locally Advanced Breast Carcinoma · Diffuse Large B-Cell Lymphoma

#DiffuseLargeB-CellLymphoma#Antibody#Phase2#monoclonal-antibody#AnatomicStageIVBreastCancerAJCCv+3
Trials 49Status Recruiting
CGTLimited DatastaleBiohaven Pharmaceuticals, Inc.Phase 3

Autologous cytokine-induced killer cell (Autologous cytokine-induced killer cell)

Small Cell Lung Cancer · Small Cell Lung Cancer

#SmallCellLungCancer#CGT#Phase3#cell-gene-therapy#CAR-T+3
Trials 46Status Active

2 / 13 pages

← PreviousNext →